Analysed IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) News Sources
Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)
04-05-2026
yahoo.com
Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance
07-05-2026
yahoo.com
Is Ironwood Pharmaceuticals, Inc. (IRWD) a Comeback Pharma Stock After Major Earnings Improvement?
20-05-2026
yahoo.com
FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)
27-05-2026
yahoo.com
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
28-05-2026
yahoo.com
Is Ironwood Pharmaceuticals, Inc. (IRWD) Strengthening Its Growth Outlook With Expanded Pediatric Approval for Linzess?
02-06-2026
yahoo.com
What is the current price of IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ)?
The current price of IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) is $3.65.
IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) absolute price change since previous trading day?
The absolute price change of IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) since the previous trading day is $0.02.
IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) percentage price change since previous trading day?
The percentage price change of IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) since the previous trading day is 0.551%.
What is the most recent average sentiment score for IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ)?
The most recent average sentiment score for IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ)?
The most recent sentiment for IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ) is .
SEC-8K** Filing Available For IRONWOOD PHARMACEUTICALS INC (IRWD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.